Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
perindopril arginine, Quantity: 5 mg
Arrotex Pharmaceuticals Pty Ltd
perindopril arginine
Tablet, film coated
Excipient Ingredients: iron oxide yellow; hypromellose; isomalt; magnesium stearate; brilliant blue FCF aluminium lake; macrogol 8000; titanium dioxide; hyprolose; colloidal anhydrous silica
Oral
10, 100, 30
(S4) Prescription Only Medicine
Treatment of hypertension and the treatment of heart failure. In such patients it is recommended that perindopril arginine be given with a diuretic and/or digoxin under close medical supervision. (The safety and efficacy of perindopril arginine has not been demonstrated for New York Heart Association Category IV patients); and patients with established coronary artery disease (See Clinical Trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.
Visual Identification: Light green coloured, capsule-shaped, biconvex, film coated tablets, with notch and engraved APO on one side and P 5 on the other side; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 30 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure
Licence status A
2012-04-26